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Abstract
Gene expression associated with West Nile virus (WNV) infection was profiled in the central nervous system of horses.
Pyrosequencing and library annotation was performed on pooled RNA from the CNS and lymphoid tissues on horses
experimentally infected with WNV (vaccinated and naı ¨ve) and non-exposed controls. These sequences were used to create a
custom microarray enriched for neurological and immunological sequences to quantitate gene expression in the thalamus
and cerebrum of three experimentally infected groups of horses (naı ¨ve/WNV exposed, vaccinated/WNV exposed, and
normal). From the sequenced transcriptome, 41,040 sequences were identified by alignment against five databases.
31,357 good sequence hits (e,10
24) were obtained with 3.1% of the sequences novel to the equine genome project.
Sequences were compared to human expressed sequence tag database, with 31,473 equine sequences aligning to human
sequences (69.27% contigs, 78.13% seed contigs, 80.17% singlets). This indicated a high degree of sequence homology
between human and equine transcriptome (average identity 90.17%). Significant differences (p,0.05) in gene expression
were seen due to virus exposure (9,020), survival (7,395), and location (7,649). Pathways analysis revealed many genes that
mapped to neurological and immunological categories. Involvement of both innate and adaptive components of immunity
was seen, with higher levels of expression correlating with survival. This was highlighted by increased expression of
suppressor of cytokine signaling 3 in horses exposed to WNV which functions to suppress innate immunity. Pentraxin 3 was
most increased in expression for all horses exposed to WNV. Neurological pathways that demonstrated the greatest
changes in gene expression included neurotransmitter and signaling pathways. Decreased expression of transcripts in both
the glutamate and dopamine signaling pathways was seen in horses exposed to WNV, providing evidence of possible
glutamate excitotoxicity and clinical signs associated with decreased dopamine. Many transcripts mapped to non-infectious
neurological disease functions, including mental disorders and degenerative neuropathies.
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Introduction
West Nile virus (WNV) is one of the leading causes of arboviral
encephalitis in the United States for both horses and humans. The
virus can be devastating in its ability to cause long term
neurological deficits and even death. Since WNV was introduced
into the United States in 1999, 25,791 clinical cases of disease have
been confirmed in horse [1]. Similarly, in humans, 30,625
confirmed cases of clinical disease have been reported with
1,202 deaths [2]. The arbovirus season of 2010, ten years after
introduction, was notably active with WNV activity detected in all
continental states. Human cases were detected in 42 states with 89
infections reported in New York and 105 infections detected in the
opposite extreme geographically in Arizona. Most of the cases
reported were of the neuroinvasive form and 45 deaths occurred.
The US blood supply continues to be at risk with 144 detections of
viremic blood obtained from donors in 2010 alone [2].
Characterization of WNV infection provides an opportunity to
enhance our understanding of the pathophysiology and immuno-
pathology of viral encephalitis in general. This is particularly
important in regards to host-pathogen interactions during
infection. During neuroinvasive disease, WNV mainly infects the
neurons of the midbrain, hindbrain, and spinal cord, with limited
infection of glial cells. Direct viral infection of CNS cells followed
by induction of the inflammatory response allows analysis of the
virus from systemic infection, to neurological spread, through
stages of innate and adaptive immunity for the purposes of
biomarker and interventional strategies. Investigation of one of the
two most commonly affected natural mammalian hosts allows
modeling of this disease under both experimental and field
settings.
WNV infection in natural mammalian hosts is characterized
clinicopathologically by an increasing number of lesions progress-
ing from the diencephalon through the hindbrain and down
through the spinal cord. Congestion of the meninges and
hemorrhagic foci may be seen. Comparatively, mice develop
disease that is primarily focused in a cerebral and cerebellar
localization of virus. Histopathologically, inflammatory lesions
characterized by layer of monocellular perivascular cuffing and
gliosis are present in horses, humans, and mice, while necrosis is
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result of many complex factors, as there is increasing evidence that
the host response to viral infection is one of the main causes of
pathology and survival during WNV infection in the CNS [5,6]. In
humans and horses, long term recovery responses are variable,
with evidence of moderate to severe congnitive, emotional, and
motor deficits in humans, and behavioral and motor deficits in
horses [7]. Thus there is a gap in our understanding of the
interactions between various components of the natural host
response to infection, and how these interactions can lead to
pathology, long term deficits, or full recovery. Given the
similarities between disease in horses and humans, equine tissue
analysis offers an unparalleled opportunity to profile gene
expression and pathway interactions between pathogens and the
CNS.
Although there are many new methods for profiling gene
expression, there is limited development of de novo deep sequencing
strategies due to limited financial resources and species specific
bioinformatics in veterinary research fields. In terms of adaptabil-
ity and computational resources, microarrays allow rapid
acquisition of tissue specific expression data for many non-model
species. Microarrays have facilitated the study of the Flaviviridae
in multiple applications including detection of variants of Dengue
virus (DV) in human samples [8], differentiation between different
flaviviral and other viral infections [9,10], and mutations in the
structural regions of the WNV genome [11]. Microarrays have
been used to analyze gene expression at both the cell culture and
organism level for DV, JEV, and yellow fever virus (YFV) infection
[12,13,14,15,16,17]. Although several species specific arrays exist,
there is limited development of tissue specific arrays in veterinary
medicine. The microarray currently developed in the horse is
based on global gene expression in which multiple tissues of the
equine transcriptome were sequenced [18]. While a valuable tool,
only cerebrum, cerebellum and spinal cord were utilized in this
work to generate transcriptome data.
Two studies have used microarrays to examine gene expression
changes in response to WNV infection. In one, human
glioblastoma cell culture transcriptional responses to WNV were
analyzed, and 23 genes involved in neurodegenerative disorders
were shown to be changed in expression [19]. In the other, a
microarray was used to analyze whole organism gene expression
response to WNV strains of different neurovirulence in a mouse
model [20]. Genes involved in immunological, neurological, and
apoptotic functions were differentially regulated (with forty-seven
genes shown to be upregulated in highly neuroinvasive strains).
No studies are available that profile gene expression in the CNS
of animals infected with WNV that are considered natural,
susceptible hosts. These data could provide detailed information
on the host response to infection and on a pathogen’s specific
manipulation of the host response, and will also allow more
efficient analysis of essential pathways in model species such as
mouse and hamster. This report provides sequencing data from
the equine brain transcriptome and lymphoid system from naı ¨ve
horses experimentally infected with WNV, vaccinated horses
experimentally infected with WNV, and negative controls. Also
described is the construction of a custom, validated equine high
density microarray, in which pathways of the CNS and immune
system were enriched. The microarray was used to profile gene
expression changes in the thalamus and cerebrum of naı ¨ve and
vaccinated horses during experimental WNV infection (and
negative controls) and common gene pathways were identified.
These data were used to detect differences in gene expression
associated with exposure to WNV, survival from WNV infection,
and location of WNV infection in the brain.
Materials and Methods
Use of Animals
All animals used in this study were used in strict compliance
with the Guide for the Care and Use of Laboratory Animals. The
protocols for the use of animals were approved by the University of
Florida Institutional Animal Care and Use Committee (IACUC
protocols F077, F093, D163). All efforts were made to minimize
pain and suffering.
Sample Selection
All tissues used in this study for library creation and array
analysis were derived from horses used in an experimental
intrathecal challenge model wherein naı ¨ve horses developed grave
West Nile (WN) encephalitis (100% nonsurvivorship) and all
vaccinated horses did not develop clinical disease (100%
survivorship). Samples for pyrosequencing and array analysis
consisted of 1) naı ¨ve horses infected intrathecally with 1610
5
WNV/NY99/crow, 2) non naı ¨ve horses vaccinated utilizing a
modified live attenuated Yellow Fever (YF) chimera vaccine for
protection against WNV (Prevenile, Intervet-Schering-Plough) and
infected intrathecally with 1610
5 WNV/NY99/crow , and 3)
horses that were not infected or vaccinated. Experimental
infection and vaccination of horses occurred according to
previously published data [4,21,22]. Horses from groups 1 and 2
were euthanized (University of Florida IACUC protocols #F077,
#F093, #D163) if demonstrating clinical signs or at the end of the
study (day 21) if not demonstrating clinical signs. Horses from
group 3 were normal healthy horses, not infected with WNV and
were euthanized due to other causes (4 of these horses were less
than 4 years of age, while 2 were over the age of 9). These causes
included lameness (angular limb deformities, chronic lameness)
and humane reasons as surrender by owner. None of the horses
were ill or demonstrating neurological signs at the time of
euthanasia (all horses underwent neurological exams). All horses
were necropsied immediately upon euthanasia. Tissues were snap
frozen in dry ice and ethanol and stored at 280uC until RNA
extraction was performed. Eight tissues were collected from each
horse and included cerebrum, cerebellum, thalamus, midbrain
(rostral and caudal colliculus, tectum, and tegmentum), hindbrain
(pons and medulla oblongata), cervical spinal cord, lumbar spinal
cord, and spleen.
A pooled tissue strategy was used to create a library that was
normalized for rare sequences that might not have been annotated
in the EqCab2 database, and that allowed for longer reads than
that accorded by directly sequencing short reads from each
individual horse. A cDNA library was constructed from a pool of
tissues mentioned above from six different horses including two
gravely ill naı ¨ve horses infected with WNV; two horses vaccinated,
infected, and recovering from WNV(vaccinated, intrathecally
infected with WNV, and survived without showing clinical signs
that warranted euthanasia according to IACUC protocols); and
two control horses that were not infected or vaccinated. Eight
tissues taken from each horse were pooled together for a final total
of 5 samples from individual horses, each containing the eight
tissues. Brain tissues used to create the cDNA for dye labeling on
the array were obtained from the archived tissues of three groups
of six horses each (total of 18 individuals) mentioned above.
Tissues used in the array included cerebrum and thalamus (one
section from each horse for a total of 36 samples).
Three analyses were established to test the hypothesis that there
are gene pathways whose expression changes in a significant and
consistent manner due to WNV as a result of exposure status,
survival/immune status, and CNS location (Table 1). With respect
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to analyze if there was a difference in gene expression between the
nonvaccinated/exposed and untreated horses (exposure), the
nonvaccinated/exposed and vaccinated/exposed horses (survival),
and the nonvaccinated cerebrum and nonvaccinated thalamus
(location). In particular, the ‘‘survivors’’ represent the gene
expression status of those animals that recover (vaccinated,
intrathecally infected with WNV, and survived without showing
clinical signs that warranted euthanasia according to IACUC
protocols) from grave WN encephalitis through induction of
vaccine mediated immunity, and the ‘‘non-survivors’’ represent
the gene expression status of naive animals undergoing grave
encephalitis.
Clinical Signs and Histopathological Grading
Neurological exams and clinical scoring were performed on
horses in all groups weekly after vaccination and daily after
infection for the horses exposed to WNV as according to
previously published data [4,21,22]. Neurological exams and
clinical scoring were also performed upon receipt for the normal
control horses. Briefly, horses were evaluated for changes in
mentation, paresis, ataxia, and muscle fasciculations. Clinical signs
and temperature were recorded from day 21 to day 21 for the
horses exposed to WNV (vaccinates and non-vaccinates). Non-
vaccinated horses and vaccinated horses exposed to WNV were
euthanized for humane reasons according to University of Florida
IACUC protocols #F077, #F093, #D163 if demonstrating severe
clinical signs or neurological disease, or at the end of the study (day
21). Normal control horses were euthanized according to
University of Florida IACUC protocols #F077, #F093, #D163
upon receipt.
Blood was drawn from each horse exposed to WNV on days 1–
14 post-infection. A PFU assay was performed on the heparinized
blood and cells observed for cytopathic effect to determine levels of
viremia. Histopathological grading was performed on sections
from the thalamus and cerebrum to investigate for the presence of
viral encephalitis (gliosis and perivascular cuffing). Scoring was
performed by two blinded and independent pathologists according
to previously published data [22]. Lesions were quantified in the
pons, medulla, cervical cord and lumbar cord. Briefly cross
sections of these areas were examined for the presence of gliosis
and perivascular cuffing. One section each was evaluated for the
pons and medulla. Two sections were evaluated for each area of
the spinal cord. Total numbers of glial nodules were counted in
each section. If more than one section was evaluated the counts for
these sections were averaged. For pervascular cuffs, 3 areas were
examined in each section and 10 vessels were counted in each
area. The number of vessels that contained inflammatory cells was
divided by the number 10. Each area per section was averaged.
Creation and Annotation of a Normalized CNS/Lymphoid
Tissue cDNA Library
The RNA isolated from the tissue samples from each horse were
pooled to create 5 samples total (eight tissues taken from each
horse were pooled together for a final total of 5 samples from
individual horses, each containing the eight tissues). The quality of
the RNA was checked using spectrophotometric technology (ND-
1000, Nanodrop Technologies, Wilmington, DE) and a micro-
fluidics platform (Agilent 2100 Bio-analyzer, Santa Clara, CA).
The RNA was converted to full-length, double-stranded cDNA
using commercial cDNA synthesis kits (SMART PCR cDNA
synthesis kit, AdvantageH 2 PCR kit, and PowerScript Reverse
Transcriptase, Clontech, Mountainview, CA). Concentration and
purity of the cDNA were assessed (Methods S1) and the purified
cDNA sample was normalized using a commercial kit encorporat-
ing an endonuclease strategy ( cDNA Normalization Trimmer Kit,
Evrogen, Moscow, Russia) according to manufacturers’ instruc-
tions.
An initial titration run was performed to ensure transcript
normalization and then two full pyrosequencing runs (Gene
Sequence 20, 454 Life Sciences, Branford, CT) were performed on
the cDNA pool. The pyrosequencing data was directly captured
by the accompanying manufacturer’s software (Peak Height
Determination Software , PyrosequencingAB), and was initially
assembled using short-read software assemblers (Ensembl, Euro-
pean Bioinformatics Institute/Wellcome Trust Sanger Institute;
Newbler, 454 Life Sciences) to identify singlets and contiguous,
non-redundant sequences. For generation of a larger set of
nonredundant sequences (contigs), additional sequence cleaning,
sequence clustering, and assembly was performed using software
that aligns and detects alternative splice forms (PTA; Paracel
Transcript Assembler, Paracell Inc, Pasadena, CA). Annotation of
these sequences was performed with the Basic Local Alignment
Search Tool analysis (BLAST) quest algorithm for storage,
management, and analysis of EST sequences (NCBI). This
consisted of a homology search using the BLASTX and BLASTN
against the NCBI databases (NT Nucleotide Database, NR
Protein Database), and equine databases (Horse draft genome
database EqCab2, EqCab2 predicted genes, and EqCab2 gene
scan). Only genes that were positively identified by BLAST with
expected values (e-values) below 10
24 were used to compile the
results.
BLAST results were further cleaned and stored in BlastQuest
(Interdisciplinary Center for Biotechnology Research, UF, Gai-
nesville, FL) to facilitate management of BLAST results and the
Table 1. Samples and analyses for the array.
Analysis Samples Tissue type WNV Challenge
Exposure Status Not vaccinated- 6 horses Thalamus Y
Untreated- 6 horses Thalamus N
Survival/Immune Status Not vaccinated- 6 horses Thalamus Y
Vaccinated- 6 horses Thalamus Y
CNS Location Not vaccinated- 6 horses Thalamus Y
Not vaccinated- 6 horses Cerebrum Y
A total of 12 tissues were compared for each of the analyses/questions asked. The questions included determining if there was a difference in gene expression due to
exposure to WNV, recovery from WNV infection, and location in the brain.
doi:10.1371/journal.pone.0024371.t001
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Assembly Filter (ICBR, UF, Gainesville, FL) was used to query the
top 100 BLAST hits for each contig against the NCBI Gene
database. This provided annotation information, gene function,
and metabolic pathway associations based on GenMAPP and
KEGG pathway database maps. The GO terms and pathway
information associated with the lowest e-value and consistent with
the NCBI databases were assigned to the query assembly process.
Contigs with the highest agreement were maintained and the least
similar sequences were eliminated. Sequence orientations were
determined by software instruments, AssemblyFilter and ESTscan
(EMBnet, Switzerland). Further analysis of sequences that were
missed by the equine genome database was then performed to
determine similarities in function by grouping like GO categories.
Sequences were analyzed for species composition between the NT
and NR NCBI databases. The complete sequenced transcriptome
was run against the human expressed sequence tag database
(Fisher cluster, UF, Gainesville, FL) to determine sequence
homology between the human and horse. An e-value of ,10
24
was set and only one match per sequence generated.
Microarray Design and Analysis
Probe sequences were based on the sequenced and annotated
cDNA library. Probes consisted of oligonucleotides (60-mer)
fabricated by a patented algorithm (Agilent Technologies, Santa
Clara, CA) based on the annotated equine brain library and a
44,000 gene array (Agilent Technologies, Santa Clara, CA).
Preference was given to probes with the greatest length, greatest
abundance, and lowest e-value (,10
24) within a cluster (set of
similar sequences). All designed probes were included with one
replicate each in 1) annotated, 2) annotated minus orientation, 3)
unannotated, and 4) recovered genome categories (Table S1).
Several probes consisting of neurological, immunological, and cell
death gene ontology categories were considered to be of particular
importance and replicates were included on the array. Uniquely
designed probes (250) designed by the manufacturer (Agilent) were
also included as technological controls on the arrays.
Total RNA was extracted and quality assessed from a total of 36
tissues (cerebrum and thalamus from 6 horses in 3 different
analyses) using the protocol outlined in Methods S1. Dye-labeled
cDNA was created using Cy3 dye (One-Color Microarray-Based
Gene Expression Analysis kit, Agilent Technologies) according to
the manufacturer’s protocols (See Methods S1) except for minor
protocol changes dictated by the CNS tissue. Hybridization to the
microarrays was performed according to the manufacturer’s
protocol (Agilent Technologies) outlined in Methods S1. All data
was submitted to the GEO microarray database according to
MIAME standards. The series record number GSE30347 was
assigned.
Normalization and Statistical Analysis
JMP Genomics version 4.0 (S.A.S. Institute, Cary, NC) was
used to analyze the data. All files were transformed (log2) and
normalized using Loess normalization techniques. Normalization
was verified using distribution analysis consisting of box plots,
correlation heat maps, and overlayed kernel density elements, and
principal component analysis consisting of 2D, 3D, and scree plots.
A two-way analysis of variance (ANOVA) was performed (location
and treatment were independent variables) and possible interac-
tions between location (cerebrum and thalamus) and treatment
(vaccinated, not vaccinated, normal) were tested in the analysis
addressing location, exposure, and survival (p,0.05). Only
thalamus was compared between the two analyses addressing
exposure and survival due to differences in gene expression
between the cerebrum and thalamus seen in the normal, non-
exposed horses. The degree of fold-change (relative fluorescent
intensity) was analyzed for all differentially regulated genes.
Variability was estimated in the software via linear regression
and Pearson correlation coeffiecient and the R square and residual
variance tables were generated for each array. A significant genes
lists was generated and a hierarchical clustering was performed.
Gene Ontology Enrichment
Probes for the analyses of location of the brain, exposure status
of the horse, and survival or recovery status of the horse that
matched to the gene ontology categories of biological process,
cellular component, and molecular function were identified. Gene
ontology categories (as derived from the original annotation of the
cDNA expression library, Fisher Cluster, University of Florida)
that involved the neurological system, immunological system,
apoptosis/cell death, and transcription/translation were targeted.
The three analyses were analyzed based on the number of
significantly different genes that grouped into these GO categories.
Pathway Modeling
Genes that showed significant up- or down-regulation (p,0.05)
with fold changes .+1o r,21 for all three statistical analyses
were extracted and databased for modeling into ontological
networks (Ingenuity Pathways Analysis software, Ingenuity
Systems, Redwood, CA). Network modeling to determine
interactions between significant genes, canonical pathways analysis
to determine genes involved in known pathways, and disease/
physiological function/location annotation was performed on
genes with fold changes .1 and ,1 and on significant genes. As
part of this computational format, Fisher’s exact test was used and
both the number of transcripts and p-values considered in ranking
of pathways, networks, and functions. This process was performed
on all significant genes as well as on the gene ontology enriched
datasets.
Microarray Validation
For the purposes of the initial validation of the utility of this
microarray, several highly significant genes (six) were selected to 1)
verify the accuracy of the probe hybridization, and 2) verify the
accuracy of the relative expression values detected by the probe.
To verify the relative expression values, only transcripts that were
significantly upregulated or downregulated (p,0.05, fold change
.2, ,22) in the exposure analysis were picked for analysis. A
total of six transcripts were targeted to be used as primer sets in the
validation experiment and included 2959 oligoadenylate synthetase
(2,5 OAS), complement component 1 (CC1), TNFa receptor
ligand (TNFR), interleukin-6 (IL-6) , DEAD Box 60 (DB60), and
defensin b4 ( DB4), with b -actin (ACT) as the endogenous control
outlined in Methods S1. Two sets of primers were designed using
primer design software (ABI Primer Express version 3.0, Applied
Biosystems). Conventional PCR was performed using a proprie-
tary master mix (Readymix Taq PCR Mastermix with MgCl2,
Sigma-Aldrich, St.Louis, MO). The reactions were resolved
utilizing a 0.9% agarose gel and imaged under standard UV
conditions. If a band(s) was visualized, the samples were submitted
to the UF Interdisciplinary Centers for Biotechnology Research
for Sanger sequencing. Sequencing results were checked against
expected gene sequences. Once the correct sequence was
validated, amplified samples were run under the thermocycling
conditions listed above using a second set of nested primers. The
presence of a band of the correct length was verified on a 0.9%
agarose gel. Relative quantitation analysis was performed using
the proprietary software for calculation of the comparative Ct
Equine Host Response to West Nile Virus Infection
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wherein 2
2DDCt is used for the comparison of relative quantitation
between the thalamus of vaccinated/exposed horses and non-
vaccinated/exposed horses. To verify the accuracy of the probe
hybridizations, the probe sequences were BLASTed against the
equine genome (Fisher Cluster, UF ICBR, Gainesville, FL). Only
sequences with e-values,1024 were generated. Sequences were
checked for percent identity and sequence alignment.
Results
Annotation and Analysis of the Sequenced Equine CNS
Transcriptome
Library Sequencing and Annotation. The quality and
purity of the RNA samples (average RIN 7.1–7.6) and cDNA
libraries can be seen in Table S2. Successful normalization was
confirmed via visualization of the bands on a gel and a titration
sequencing run. In total, 308 contigs were identified with an
average length of 208.1 base pairs. Only 4 large contigs were
identified, confirming that normalization was effective.
After linkers and repetitive sequences were removed, 514,462
sequences were assembled from a total of 49,857,586 bases using
Newbler Assembly filter software. Fully assembled reads, partially
assembled reads, singletons, repeats, outliers and contigs were
identified. A total of 16,895 contigs were identified (1,902 large
contigs) (Table S3). The sequences obtained from the three
assembly analyses included 16,895 contigs obtained from the
Newbler assembly, 443,584 unannotated sequence sets from the
454 sequencing run, and 22,748 sequences from Ensembl. These
sequences were databased and assembled using PTA for a total of
188,885 final sequences (Table 2). Clusters were determined
(overlap 100 base-pair minimum) and 61,499 sequences matching
with ‘seed’ sequences were clustered. Sequences that were not
identified as ‘seed’ sequences (127,386) were clustered in three
steps via partitioning, pairwise comparison, and clustering.
Combining the results from Newbler and PTA analyses and
utilizing known sequences from the equine genome databases,
19,987 contigs and 21,053 genes were assembled. Unassembled
sequences were not considered for further analysis. In total, 41,040
sequences were used in the BLAST analysis [19,679 PTA contigs
(=11,621 non-seeded contigs+8,058 seeded contigs), 308 newbler
contigs and 21,053 unassembled EquCabv2 genes]. These
sequences have been submitted to GenBank (NIH) for public
access (study # SRP000619).
Library Analysis. A BLAST search was run against five
separate databases (e-value 10
24 ) and 31,357 good sequence hits
were obtained (Table 3). Approximately 73.7% of the sequences
identified in this project were matched in the equine chromosome
database and at least one of the equine predicted genes databases,
while 23.1% of the sequences recognized in this project were only
identified in the equine chromosome database. Completely novel
genes yet to be identified by the equine genome project were
represented by 3.1% (1,278) of the sequences identified. The
average HspScores and bit scores for all equine databases indicated
a high degree of alignment of the sequences with those in the equine
databases. All sequences demonstrated significant length for
Table 2. Data from 454 Sequencing Runs Paracel Transcript Assembler.
Classification Number of Sequences
No. of current input sequences 483,227
No. of sequences removed during cleanup 294,342 (609 were EquCabv2 genes)
No. of sequences kept after cleanup 188,885 (22,139 were EquCabv2 genes)
No. of sequences in seed clusters 61,499
No. of sequences pairwise compared 127,386
No. of singlets after pairwise compared 75,413
No. of problem sequences 54
No. sequences in clusters 51,919
No. of seed clusters 21,421
No. of clusters 11,634
Largest cluster cl.007 (2,998)
2
nd largest cluster cl.015 (2,721)
Largest seed cluster sd.17584 (112)
2
nd largest seed cluster sd.3613 (105)
No. final assemblies 134,844
No. of cluster.contigs 11,621
No. of cluster singlets 2,098 (4 genes+19 newbler contig+2,075 reads)
No. of seed cluster.contigs 8,058
No. of seed cluster singlets 37,654 (*21,021 genes+29 newbler contig+2,498 reads)
No. of PTA contigs 19,679 (11,621+8,058)
No. of singlet 75,413 (28 genes+260 newbler contig+75,125 reads)
No. of contigs 19,987 (=11,621+8,058+19+29+260)
No. of genes 21,053 (=4+21,021+28)
doi:10.1371/journal.pone.0024371.t002
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demonstrated positive identity greater than 95% (Table S4).
Gene ontology analysis was performed on the library.
Consistent with the utilization of CNS and immune tissues, a
heavy bias towards those genes involved with the immune system,
the CNS, and programmed cell death (apoptosis) was identified by
GO analysis of the assembled contigs and genes. This method-
ology also allowed the identification of novel genes involved in the
immune response and neurologically specific genes in equine
tissues (Figure S1a, S1b).
The sequences were analyzed using the NCBI database and
matching to known species in the database made. With an e-
value#10
24 for all databases, there were 39,257/41,040 accurate
hits for both the NR and NT NCBI databases. For the NR
database alone, there were 30,011 accurate hits with 26,955
‘perfect’ (e-value=0) hits, while for the NT database, there were
39,217 accurate hits with 32,825 ‘perfect’ hits. For both databases,
matches to horses comprised the greatest number of hits with the
species groups humans, primates, canines, and bovines containing
the next greatest number of hits (Figure S2a, S2b).
All sequences that were not previously identified (novel) were
analyzed. Of the 1,280 (3.1%) sequences not recognized by any of
the equine databases, 709 (55.4%) were classified into gene
ontology databases. With overlap, 579 could be classified into
biological processes, 592 into cellular component, and 619 into
molecular function. The average length of all these sequences was
595 base pairs with a range of 50–8,802 base pairs (Figure S3).
Finally, the sequences were compared to the human expressed
sequence tag database (e-value#10
24 ) (Table 4). A high degree of
sequence homology between the human and equine transcriptome
was found, with percentage matches of 69.27% (contigs), 78.13%
(seed contigs), and 80.17% (singlets). Equine sequences demon-
strated good match to the human EST database with an average
percent identity of 90.17%, an average bit score of 512.91, and an
average alignment length of 424.85.
Gene Expression Analysis
With respect to the experimental groups, three analyses were
performed to determine if there was a difference in gene
expression based on exposure status (the thalamic nuclei of the
infected vs noninfected, nonvaccinated horses), immune status/
survivorship (the thalamic nuclei of the infected vs infected,
vaccinated horses), and location (the thalamic nuclei of the
infected nonvaccinated cerebrum and infected nonvaccinated
thalamus). These experimental groups and the tissue types tested
are outlined in Table 1.
Loess normalization was performed on all arrays and confirmed
by distribution analysis (Figure S4). For all arrays, the majority of
variance was accounted for in the first three principal components
(x, y, and z) with Eigenvalues (percents of variability) of the each
component, 11.09 (30.81%), 4.94 (13.71%, and 3.21 (8.94%),
respectively. In addition, the mean of the R
2 was 0.939392 (range
0.8781–0.9871) for all arrays. A heat map and dendrogram was
generated between all arrays (Figure S5).
Statistical analysis was performed using analysis of mean relative
difference in gene expression. An ANOVA with interactions
between treatment and location revealed significant differences in
gene expression (p,0.05) for all comparisons, including those
between exposure status, survival status, and CNS location. For
the normal, non-challenged horses, there were 6,911 genes that
showed showed significantly different levels of expression between
cerebrum and thalamus after duplicate removal. Therefore, for the
Table 3. Summary of BLAST Results for Five Separate Databases.
Count % NR/NT
Equ-Cab2
Chr.
Equ-Cab2
Predicted
Genes
Equ-Cab2
GeneScan
Newbler
Contigs
Cluster
Contigs
Seeded
Cluster
Contigs
Equ-Cab2
Genes
28,789 70.1 !! ! 58 412 7,760 20,559
817 2.0 !! 6 37 360 219 201
652 1.6 ! 6 ! 11 641 0 0
5,391 13.1 e-value* ! 6665 5,326 0 0
2,462 6.0 e-value‘ ! 6661 2,401 0 0
1,651 4.0 ! 6650 1,601 0 0
677 1.6 e-value* 66 6 13 299 79 286
287 0.7 e-value‘ 66 6 9 273 0 5
314 0.8 66 6 4 308 0 2
41,040 308 11,621 8,058 21,053
*=e-value,1e
220,
‘=e-value,1e
24.
doi:10.1371/journal.pone.0024371.t003
Table 4. Summary of BLAST Analysis of Sequenced Equine
Transcriptome to the Human Expressed Sequence Tag
Database.
Contigs Seed Contigs Singlets
Number of Matches
E#10
24
8050/11621 6296/8058 17127/21361
Percent Homology
Match
69.27% 78.13% 80.17%
Average E value 1.44636E-05 2.38671E-06 8.09623E-06
Average Bit Score 189.0196894 907.9956004 519.9152099
% Identity 89% 91% 90%
Alignment Length 187.9218634 698.33831 435.6858761
Contigs, seed contigs, and singlets from this project were BLASTed against the
human EST database. In total, 31,473 sequences matched to the human EST
database (row 1) with an e-value#10
24.
doi:10.1371/journal.pone.0024371.t004
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The three analyses were compiled and 3,421 of the same genes
were significantly altered in all comparisons.
For exposure status, significant differences in gene expression in
the thalamus were seen between nonvaccinated/exposed and
normal, nonexposed horses for 9,020 genes (Table S5). When
analyzed solely by fold change, 2,936 genes decreased by ,21.0
(395,22.0) and 2,084 increased by .+1.0 (749.+2.0). For
immune/survival status, significant differences in gene expression
in the thalamus were seen between nonvaccinated/exposed horses
(nonsurvivors) and vaccinated/exposed horses (survivors) in 7,395
genes (Table S5). In the nonvaccinated, nonsurvivors, 2,123 genes
were decreased by ,21.0 (225,22.0) while 1,800 were increased
by .+1.0 (666.+2.0) compared to the vaccinated, survivors.
Finally, where analyzed by location in the brain, significant
differences in gene expression were seen between the cerebrum
and thalamus of nonvaccinated horses exposed to WNV (location)
for 7,649 individual genes (Table S5). For the location analysis,
2,053 genes were decreased by ,21.0 (609,22.0) while 1,827
were increased by .+1.0 (406.+2.0).
Exposure Status. Gene ontology was explored for the
exposure status. The first subhypothesis asked whether there was
a difference in gene expression due to exposure to WNV between
nonvaccinated horses exposed to WNV and normal horses not
exposed to WNV. Genes that were found to have significant
differences in expression were classified into the gene ontology
(GO) categories of biological process, cellular component, and
molecular function (Figure S6a). Within these categories, 2,022
genes mapped to components of transcription and RNA
processing, 1,081 mapped to neurological categories, 983 genes
mapped to immunological categories, and 420 mapped to cell
death or apoptosis (430) (Figure S6b).
Canonical pathways were first examined for interactions
between multiple significant transcripts in the exposure status.
The majority of pathways were involved with some aspect of cell
signaling for all groups (Table S6). Seventeen neurological
pathways were identified with significantly changed transcriptional
levels when nonvaccinated horses exposed to WNV were
compared with normal horses not exposed to WNV (Figure 1).
The canonical pathways involved consisted mainly of neurotrans-
mitter and signaling pathways with extensive involvement of
glutamate receptor signaling (Figure 2a, Table 5) and dopamine
receptor signaling (Figure 2b, Table 5). Neurological pathways
containing the most molecules when the WNV infected horses
were compared to the noninfected horses (15 or more) included
axonal guidance signaling, CREB signaling in neurons, synaptic
long term depression, and Huntington’s disease signaling
(Figure 1).
Regarding immunological canonical pathways and WNV
exposure status, 47 pathways were identified (Figure 3) and
Figure 1. Neurological canonical pathways for all analyses. Canonical pathways identified as significant for each analysis were selected. There
was a high degree of overlap between all three analyses in neurological pathways. The location analysis contained transcripts that mapped to the
most neurological pathways. The green line represents significance. For the purposes of this study, ‘exposure’ represents the difference in gene
expression between the nonvaccinated/exposed-normal, ‘survival’ represents the difference in gene expression between the nonvaccinated/
exposed-vaccinated/exposed, and ‘location’ represents the difference in gene expression between the thalamus and cerebrum of the nonvaccinated/
exposed.
doi:10.1371/journal.pone.0024371.g001
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which there was upregulation in horses exposed to WNV included
the IL-15 signaling pathway, the IL-22 signaling pathway, the IL-9
signaling pathway, and the Interferon Signaling Pathway
(Figure 4a,b, Table 6). Multiple pathways involved in apoptosis
were dysregulated (both up and down) in horses with exposure to
WNV and these included the retinoic acid mediated apoptosis
signaling, calcium-induced T lymphocyte induced apoptosis,
cytotoxic T lymphocyte mediated apoptosis of target cells,
induction of apoptosis by HIV1, and April mediated signaling.
Genomic functions analysis links the top transcripts in each
pathway to reported disease states and normal function. The
functions were distributed amongst many analyses and, in
particular, neurological, immunological, and cell death pathways
(Table S7) were represented. In horses exposed to WNV
compared to normal horses, four categories were identified
involving neurological functions (2,326 transcripts), 10 categories
were identified involving immunological functions (1,830 tran-
scripts for exposure), and 1 category was identified as involving cell
death (1,153 transcripts exposure).
The genes in the functions from neurological categories were
grouped mainly under neurological disease when compared to
nervous system development and function, behavior, and psycho-
logical disease. When further analyzed by specific disease, genes
mapped to mental disorders (including bipolar affective disorder,
Alzheimer’s, and schizophrenia), as well as degenerative neuropa-
thies (including progressive motor neuropathy, Huntington’s
disease, Parkinson’s disease, amytrophic lateral sclerosis, and
multiple sclerosis) (Figure 5 a,b).
The functions involving immunological pathways were grouped
with cell death/apoptosis for analysis. The most genes were
categorized under inflammation (992 transcripts). Both innate
(inflammatory response, antigen presentation, immune cell
trafficking) and adaptive (humoral immune response, cell-mediat-
ed immune response, cytotoxicity, immune cell trafficking) aspects
of immunity were identified. Cell death and apoptosis categories
were also seen for the exposure analysis, with 1,299 total genes
involved with cell death, and 1,006 total genes involved with
apoptosis (Figure S7).
Transcripts that were increased in expression by 1-fold or more
or decreased in expression by -1-fold or less and mapped to the
IPA database were included. There were 176 neurological
transcripts downregulated and 43 neurological transcripts upre-
gulated (Table 7) for the exposure analysis. Transcripts involved
with neurotransmitter pathways including glutamate receptor
signaling (Figure 2a, Table 5) and dopamine receptor signaling
(Figure 2b, Table 5) were of particular note. Catenin (cadherin-
associated protein), delta 2 (neural plakophilin-related arm-repeat
protein) (CTNND2) was also highly upregulated.
There were 176 immune transcripts downregulated and 130
immune transcripts upregulated (Table S8). The most notable was
pentraxin 3 (PTX3), upregulated over 9-fold. Transcripts that
mapped to specific immunological pathways of interest that were
significantly changed in expression included those that mapped to
Figure 2. Glutamate and Dopamine Receptor Signaling Pathways. (A) The diagrams represents signaling in the synaptic cleft (square=pre-
synaptic neuron, oval=post-synaptic neuron, circle=glial cell). Green represents downregulation of pertinent receptors, red represents upregulation
of pertinent receptors. WNV induces downregulation of glutamate receptors on the post-synaptic cleft as well as glutamate uptake receptors on glial
cells. (B) Dopamine receptor signaling pathway. The graphic shown is for the exposure analysis, but was similar in all analyses. Green represents
down-regulation of transcripts, red represents upregulation. Dopamine receptors (DRD5) and downstream signaling pathways as well as enzymes
that create dopamine (TH) were downregulated, while MAO (enzyme that degrades dopamine) was upregulated. This network was generated
through the use of IPA (Ingenuity Systems, www.ingenuity.com).
doi:10.1371/journal.pone.0024371.g002
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Entrez Gene Name GenBank Exposure
Exposure
(p-value) Survival
Survival
p-value Location
Location
p-value
Adenylate cyclase 1 (brain)* NM_174229 21.789 1.78E-02 21.898 1.25E-02
Adenylate cyclase 2 (brain)* XM_851103 21.683 28.70E-08 21.223 4.90E-06 22.027 6.80E-09
Adenylate cyclase 5* NM_183357 21.258 2.07E-02 21.379 1.19E-02
Adenylate cyclase 8 (brain)* XM_539166 21.021 2.11E-02 21.954 4.50E-05
Adenylate cyclase 9* BC151229 21.46 5.00E-04
Calcium/calmodulin-dependent
protein kinase IV‘
XM_517873 21.976 6.20E-03
Dopamine receptor D5* XM_604584 21.097 1.72E-02
GTP cyclohydrolase 1* XM_846790 1.296 3.00E-03
Glutaminase‘ AC005540 21.009 9.00E-04
Guanine nucleotide binding protein
(G protein), beta polypeptide 1‘
BC004186 21.638 7.80E-03
Guanine nucleotide binding protein
(G protein), gamma 5‘
BC003563 1.359 4.40E-05
Glutamate receptor, ionotropic, AMPA 1‘ XM_001169416 21.398 1.34E-02 21.057 5.00E-04 21.498 3.00E-04
Glutamate receptor, ionotropic, AMPA 2‘ NM_000826 21.505 4.00E-03 21.643 3.90E-05
Glutamate receptor, ionotrophic, AMPA 3‘ NM_007325 22.33 2.50E-03 22.719 3.00E-04
Glutamate receptor, ionotrophic, AMPA 4‘ NM_000829 1.253 1.50E-02 21.039 3.10E-03
Glutamate receptor, ionotropic, delta 2‘ AC022317 21.581 1.00E-04
Glutamate receptor, ionotropic, kainate 1‘ NM_000830 21.098 2.59E-02 21.933 1.57E-02 22.626 3.00E-04
Glutamate receptor, ionotropic, kainate 2‘ XM_866973 21.533 1.57E-02
Glutamate receptor, ionotropic, N-methyl
D-aspartate 1‘
AF015731 21.949 6.00E-03 21.487 1.99E-02
Glutamate receptor, ionotropic, N-methyl
D-aspartate 2A‘
XM_547132 22.836 1.00E-04 21.631 2.85E-02 22.369 1.00E-03
Glutamate receptor, ionotropic, N-methyl
D-aspartate 2B‘
AC007535 21.563 7.40E-03 21.989 2.05E-02
Glutamate receptor, ionotropic, N-methyl-
D-aspartate 3A‘
XM_862276 21.032 1.10E-03
Glutamate receptor interacting protein 1‘ XM_001162097 21.23 2.83E-02
Glutamate receptor, metabotropic 8‘ AC079957 21.856 1.14E-02
Homer homolog 1 (Drosophila)‘ XM_001139767 21.084 2.81E-02
Homer homolog 3 (Drosophila)‘ XM_541929 21.718 1.10E-03 21.134 2.31E-02
Interleukin 4 induced 1* AY358933 3.176 3.00E-05 3.265 2.00E-05 1.405 3.79E-02
Protein phosphatase 1, regulatory
(inhibitor) subunit 14A*
XM_867134 22.083 1.10E-03
Protein phosphatase 1, regulatory
(inhibitor) subunit 3C*
BT030698 22.27 9.00E-04 21.746 7.00E-12 21.686 2.00E-11
Protein phosphatase 2 (formerly 2A),
regulatory subunit B, beta isoform*
XM_001159292 22.348 1.00E-04 1.14 3.49E-02
Protein phosphatase 2 (formerly 2A),
regulatory subunit B, gamma isoform*
XM_001250700 21.243 2.80E-03 21.378 1.10E-03 21.446 7.00E-04
Protein kinase, camp-dependent,
catalytic, beta*
XM_862471 22.225 7.00E-04
Protein kinase, camp-dependent,
regulatory, type II, beta*
XM_001148361 21.627 2.20E-03
Solute carrier family 1 (glial high affinity
glutamate transporter), member 2‘
NM_004171 21.639 1.53E-02 22.869 7.80E-06 22.278 2.00E-04
Solute carrier family 17 (sodium-dependent
inorganic phosphate cotransporter), member 7‘
NM_001098046 21.598 8.23E-02 22.652 4.20E-03 28.147 9.50E-08
Tyrosine hydroxylase* BC149072 22.857 1.00E-03
*-Involved with Dopamine Signaling Pathway,
‘- Involved with Glutamate Signaling Pathway.
doi:10.1371/journal.pone.0024371.t005
Equine Host Response to West Nile Virus Infection
PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e24371Figure 3. Immunological Canonical Pathways for All Analyses. The location analysis contained transcripts that mapped to the most
immunological pathways. The green line indicates significance. For the purposes of this study, ‘exposure’ represents the difference in gene expression
between the nonvaccinated/exposed-normal, ‘survival’ represents the difference in gene expression between the nonvaccinated/exposed-
vaccinated/exposed, and ‘location’ represents the difference in gene expression between the thalamus and cerebrum of the nonvaccinated/exposed.
doi:10.1371/journal.pone.0024371.g003
Figure 4. IL-15 Production Pathway and IL-22 Signaling Pathway. (A) The diagrams represent the different methods of IL-15 production.
Green represents downregulation of pertinent molecules, red represents upregulation of pertinent molecules. WNV induces upregulation of the
production of IL-15. (B) Red represents upregulation of gene expression, green represents down-regulation of gene expression. The JAK/STAT portion
of the pathway is upregulated during viral infection, demonstrating an innate immune response. However, the SOCS3 molecule is also upregulated,
indicating that infection with the virus may lead to subsequent suppression of the JAK/STAT pathway and evasion of the innate immune response.
This network was generated through the use of IPA (Ingenuity Systems, www.ingenuity.com).
doi:10.1371/journal.pone.0024371.g004
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JAK/STAT pathways (Figure 4a,b, Table 6). Transcripts involved
in apoptosis were also upregulated in WNV infected horses
compared to normal horses, including poly (ADP-ribose) poly-
merase family member 14 (PARP), caspase 4 (CASP4) retinoid
receptor (RXR), and retinoic acid nuclear receptor (RAR).
Immune/Survivor Status. Gene ontology was investigated
for the immune/survivor status. Horses that survived infection (all
vaccinated before experimental infection) were compared to
horses that succumbed to grave neurological diseases (no vaccine
before experimental infection). Because of experimental design to
allow for assessment of survivorship, nonsurviving horses were
analyzed at an average of 7–9 days post-infection compared to
survival horses at 21 days post-infection. Similar to previous
analysis performed between exposed and nonexposed horses,
genes that were found to be significantly different in expression
belonged to three major gene ontology (GO) categories (Figure
S6a). The most genes mapped to GO processes of transcription/
RNA processing (1,864) with the second most genes mapping to
immunological categories (850). Genes also mapped to
neurological categories (840) and cell death/apoptosis (338)
(Figure S6b).
For this analysis, the majority of canonical pathways engaged
cell signaling for a variety of cell types, functions and transcripts
(Table S6). Ten of the top 25 pathways (based on the p-value) were
classified as neurological pathways composed of 156 transcripts.
None of the top 25 pathways were identified as immunological
pathways.
The neurological canonical pathways were analyzed for
nonsurvivorship and 19 pathways were identified (Figure 1). Like
the analysis for exposure status, specific neurological pathways that
demonstrated dysregulation included neurotransmitter pathways
and signaling pathways with glutamate receptor signaling
(Figure 2a, Table 5) and dopamine receptor signaling (Figure 2b,
Table 5) highly represented once again. The pathways with the
most molecules ( greater than 15) involved included axonal
guidance signaling, CREB signaling in neurons, synaptic long
term depression, neuropathic pain signaling in dorsal horn
neurons, synaptic long term potentiation, and glutamate receptor
signaling.
Forty-nine pathways involved in both the innate and adaptive
immunity were identified as associated with immune/survivorship
status (Figure 3). Some of the major immune pathways that were
upregulated included the IL-15, IL-22, IL-9, and IFN signaling
pathways (Figure 4a,b, Table 6). Multiple pathways involved in
apoptosis were also dysregulated and these included the retinoic
acid mediated apoptosis signaling, calcium-induced T lymphocyte
induced apoptosis, and death receptor signaling.
Five neurological function categories involving 2,246 transcripts
were identified as significantly altered when surviving horses were
compared with nonsurviving horses, while nine categories were
identified involving immunological functions (1,542 transcripts),
and one category was identified involving cell death (1,082
transcripts exposure) (Table S7).
In the analysis of specific neurological categories, more genes
grouped under neurological disease when compared to nervous
system development and function, behavior, and psychological
disease. When further analyzed by specific disease, genes mapped
to the similar mental and degenerative disorders identified by the
previous analysis (Figure 5 a,b).
Functions similar to those identified in the previous exposure
analysis were noted when deeper analyses of immunological and
apoptosis functions was performed. Genes were mostly commonly
categorized under inflammation (832 transcripts), with both innate
and adaptive immune functions identified. In total, 476 total genes
were involved with cell death, and 340 genes were involved with
apoptosis (Figure S7).
Individual significantly upregulated and downregulated tran-
scripts were analyzed for their association with nonsurvival (naı ¨ve
horses infected with WNV). A total of 209 neurological transcripts
Table 6. Levels of Expression of Transcripts in Immunological Pathways of Note.
Entrez Gene Name GenBank Exposure
Exposure
p-value Survival
Survival
p-value Location
Location
p-value
Interleukin 15* AK290619 2.369 7.40E-06 2.29 1.20E-05 2.004 4.00E-03
Interferon regulatory factor 3* AK292027 1.31 1.80E-03 1.935 2.00E-05 1.086 3.32E-04
Janus kinase 1*‘ XM_001161295 1.079 1.10E-03
Mitogen-activated protein
kinase kinase 1*‘
XM_612526 21.4 3.79E-02
Mitogen-activated protein kinase 1*‘ NM_002745 21.095 6.40E-03 21.061 9.50E-03
Protein inhibitor of activated STAT, 2‘ XM_612798 21.014 1.20E-02
Phosphoinositide-3-kinase, regulatory
subunit 1 (alpha)*‘
NM_181504 21.062 3.00E-04 21.339 1.00E-04
Phosphoinositide-3-kinase, regulatory
subunit 2 (beta)*‘
XM_847313 22.44 2.40E-03 22.341 1.15E-02
Phosphoinositide-3-kinase, regulatory
subunit 3 (gamma)*‘
XM_856294 1.537 2.43E-02
PTK2B protein tyrosine kinase 2 beta* XM_543228 21.029 8.60E-03 21.545 1.10E-03
Suppressor of cytokine signaling 3‘ NM_174466 1.535 1.45E-02 1.809 4.60E-03
Signal transducer and activator of
transcription 1, 91kda*‘
BC151378 3.021 3.00E-18 3.763 5.00E-20 2.384 1.00E-14
Tyrosine kinase 2*‘ XM_590006 1.504 2.00E-04
*- Involved with IL-15 Signaling Pathway,
‘- Involved with IL-9;IL-22;JAK/STAT Signaling Pathways.
doi:10.1371/journal.pone.0024371.t006
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increased in expression (Table 7). Similar to previous analyses,
these transcripts were primarily involved with neurotransmitter
pathways including glutamate and dopamine receptor signaling
(Figure 2ab, Table 5).
Further analysis of the transcripts involved in the immune
response in the nonsurvivors identified 215 downregulated and
116 upregulated immune transcripts (Table S8). The transcript
increased most in expression was PTX3 exhibiting a 7.7-fold
increase in nonsurviving horses compared to surviving horses.
Transcripts that mapped to separate immunological pathways that
were significantly changed in expression included those that
mapped to the IL-15, IL-9, IL-22, and JAK/STAT pathways
(Figure 4a,b, Table 6). Transcripts predominantly involved in
apoptosis were also upregulated for the nonsurvivors and examples
included (PARP) and caspase 4.
CNS Location. Gene ontology was analyzed for CNS
location. The third subhypothesis asked whether there was a
difference in gene expression due to location in the brain during
WNV infection between thalamus and cerebrum, and for this only
infected, nonvaccinated horses were analyzed. The transcripts
were mapped to the three major GO categories (Figure S6a). Most
genes mapped to GO processes of transcription/RNA processing
(1,664) with the second most genes mapping to immunological
categories (798). Genes also mapped to neurological categories
(447) and cell death/apoptosis (349) (Figure S6b).
Canonical pathways analysis was performed on the data in the
location status. Similar to previous analyses, the majority of
pathways affected and differentially expressed were involved with
cell signaling (Table S6). Seven of the top 25 pathways were
identified as important in neurological processes (125 transcripts)
while two of the top 25 pathways were identified as immunological
processes (40 transcripts).
Sixteen canonical pathways were significantly affected based on
differences in CNS location (Figure 1). Like the exposure and
survivor analysis, neurotransmitter pathways and signaling
pathways were heavily involved, including glutamate receptor
signaling (Figure 2a, Table 5) and dopamine receptor signaling
(Figure 2b, Table 5). Pathways with greater than 15 molecules
involved included axonal guidance signaling, CREB signaling in
Figure 5. Neurological Functions for All Analyses. (A) Neurological disease and psychological disorders categories, and (B) Nervous system
development and function and behavior categories. The majority of transcripts mapped to neurological disease. The red bars represent the exposure
analysis, the purple bars the survival analysis, and the orange bars the location analysis. The diamonds represent the p-value for exposure, the
triangles the p-value for nonsurvival, and the squares the p-value for location. For the purposes of this study, ‘exposure’ represents the differencei n
gene expression between the nonvaccinated/exposed-normal, ‘survival’ represents the difference in gene expression between the nonvaccinated/
exposed-vaccinated/exposed, and ‘location’ represents the difference in gene expression between the thalamus and cerebrum of the nonvaccinated/
exposed.
doi:10.1371/journal.pone.0024371.g005
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in dorsal horn neurons, Huntington’s disease signaling, synaptic
long term potentiation, and neureglin signaling (Figure 1).
Forty-eight immunological canonical pathways (Figure 3) in-
volving both the innate and adaptive response were detected as
significantly involved. The immune pathways that were upregu-
lated (Figure 4a,b, Table 6) included the same previously identified
signaling pathways (IL-15, IL-22, IL-9 and IFN). Multiple
pathways involved in apoptosis were also dysregulated in the
location analysis. These included the retinoic acid mediated
apoptosis signaling, calcium-induced T lymphocyte induced
apoptosis, cytotoxic t lymphocyte mediated apoptosis of target
cells, induction of apoptosis by HIV1, and apoptosis signaling, and
myc mediated apoptosis signaling.
Five categories were identified involving neurological functions
(3,242 transcripts), ten categories were identified involving immuno-
logical functions (1,558 transcripts), and one category was identified
as involving cell death (719 transcripts) (Table S7). The further
analysesofspecificneurologicalfunction weresimilartothatmapped
for both the exposure and immune status analyses (Figure 5 a,b).
The functions involving immunological pathways were grouped
with cell death/apoptosis for analysis. Like the previous analyses,
most genes were categorized under inflammation (834 transcripts),
with involvement of both innate and adaptive immunity. Cell
death and apoptosis categories were also seen for the location
analysis, with 210 total genes involved with cell death, and 184
total genes involved with apoptosis (Figure S7).
Neurological transcripts were significantly changed in expres-
sion (Table 7). A total of 176 transcripts were downregulated and
43 transcripts were upregulated. Transcripts of note were similar
to the previous analyses. This included a decrease in transcripts
involved with glutamate signaling and dopamine signaling
pathways (Figure 2a,b, Table 5). The protein CTNND2 was also
highly upregulated.
In total, 266 immune transcripts were downregulated, while 210
transcripts were upregulated (Table S8). PTX3 was upregulated
over 4-fold. Other immunological transcripts significantly changed
in expression were similar to the analyses involving exposure and
immune status. These included those that mapped to the IL-15
pathway and those that mapped to the IL9, IL22, and JAK/STAT
pathways (Figure 4a,b, Table 6). Apoptotic transcripts were also
upregulated in the location analysis and were similar to that of
immune/survivorship status, including poly (ADP-ribose) poly-
merase family member 14 (PARP), and caspase 4 (CASP4).
Comparison of Histopathological Data and Clinical Signs
with Gene Expression Data. All horses were evaluated for
Table 7. Transcripts for all analyses mapped to neurological CPs.
Exposure
Decreased
Exposure
Increased
Survival
Decreased
Survival
Increased
CNS Location
Decreased
CNS Location
Increased
Agrin Interactions at Neuromuscular Junction 1 4 2 2 2 4
Amyloid Processing 4 1 3 1 3 3
Amyotrophic Lateral Sclerosis Signaling 11 1 14 0 13 2
Axonal Guidance Signaling 25 6 22 7 19 10
CDK5 Signaling 11 0 9 0 10 2
Cholecystokinin/Gastrin-mediated Signaling 5 2 7 2 6 1
Circadian Rhythm Signaling 2 1 4 1 5 1
CNTF Signaling 1 2 2 1 4 3
CREB Signaling in Neurons 15 4 19 2 20 4
Docosahexaenoic Acid (DHA) Signaling 2 0 2 1
Dopamine Receptor Signaling 10 1 6 2 6 2
GABA Receptor Signaling 6 0 6 0 8 0
Glutamate Receptor Signaling 8 1 15 0 12 1
GNRH Signaling 12 3 11 1 13 2
Huntington’s Disease Signaling 10 5 8 5 12 7
Melatonin Signaling 6 1 10 1 8 1
Neuregulin Signaling 6 3 10 6
Neuropathic Pain Signaling In Dorsal Horn Neurons 8 2 16 1 17 2
Neurotrophin/TRK Signaling 5 0 4 0 6 2
Reelin Signaling in Neurons 4 2 3 3 5 5
Regulation of Actin-based Motility by Rho 3 2
Semaphorin Signaling in Neurons 6 1 5 2 2 1
Serotonin Receptor Signaling 1 1 0 2 1 1
Synaptic Long Term Depression 14 4 17 3 17 3
Synaptic Long Term Potentiation 11 1 15 1 17 1
Total 176 43 209 42 218 65
This table shows the number of transcripts that mapped to each pathway for all analyses. The majority of the transcripts demonstrated a decrease in expression values.
Transcripts were included if they demonstrated a fold change .1o r,21.
doi:10.1371/journal.pone.0024371.t007
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non-vaccinated horses (exposure group) all demonstrated ataxia
and muscle fasciculations. The majority of these horses also
demonstrated a change in mentation (4/6) and/or paresis (5/6)
(Table S9). All of the exposed naı ¨ve horses developed clinical signs,
half developed a fever, and all were humanely euthanized
(Table 8). Infected vaccinated horses and normal control horses
did not develop clinical signs, signs of neurological disease, or fever
(Table 8). Viremia was detected in non-vaccinated exposed horses
from days 1–5 post infection, but not in the vaccinated exposed
horses [22].
For histopathological analysis, all horses in the non-vaccinated
exposed group demonstrated moderate or severe encephalitis on
histopathology (Table 8). This pathology was graded according to
the degree of gliosis and/or perivascular cuffing and was more
severe in the thalamus of these horses compared to the cerebrum
(Table 9). Mild signs of encephalitis were seen in 1 out of the 6
infected, vaccinated horses (Table 8). These inflammatory changes
were more severe in the thalamus than in the cerebrum (Table 9).
No abnormal histopathology was seen in the cerebrum or
thalamus of the normal control horses. The severity of the clinical
signs and histopathology in the non-vaccinated horses exposed to
WNV, compared to the exposed vaccinates and normal controls, is
consistent with the changes in gene expression seen between the
analyses of exposure and survival. This is likewise true for the
location analysis when examining the histopathological differences
between the thalamus and cerebrum of the exposed, non-
vaccinated horses.
Array Validation
The correct sequences (checked against the sequences from the
transcriptome) were identified for the primer pairs b-actin,
2959OAS, CC1R, IL-6, DEADBox60, Defensin b 4, and TNF-
a. b -actin was included as the ‘house-keeping gene’, and the other
genes were significantly up-regulated. Primer efficiencies were
established for all primer pairs using standard curves analysis and
efficiency calculation, with efficiencies ranging between 85 and
97%. Real time relative quantitative PCR was then performed on
the thalamus from 6 of the vaccinated and exposed horses and 6 of
the non-vaccinated and nonexposed horses, with b actin as the
endogenous control (Table 10). There was a relative increase in
expression for all primer pairs which correlated with the
microarray data.
Microarray probe sequences were analyzed by comparison to
the most recent version of the EqCab2 genome using the basic
local alignment search tool (BLAST, Fisher Cluster, University of
Florida, Gainesville, FL) to determine the accuracy of each
sequence to detect single genes as opposed to gene families. In
total, 42,843 oligonucleotide probes were analyzed and 40,113
probes matched to one sequence with 100% identity (93.6%). Of
these, 3,700 (9.2%) matched more than once to a genomic
sequence implying possible binding to a gene family. The majority
of these which matched to multiple sequences were identified as
belonging to one chromosome. In addition, 2,687 probes matched
at ,100% identity (average 97.5% identity). Forty-three probes
did not match, and were most likely present as controls since the
sequences could not be detected in the sequenced library.
Discussion
This project sequenced all levels of equine brain and spinal cord
transcriptome to analyze global gene expression in the CNS of
natural, outbred equine hosts during grave WNV encephalitis.
The data generated from this project provides invaluable insight
into WN encephalitis in horses and possibly humans, and is a
useful platform for future studies for both pathological and non-
pathological applications. In the sequencing and analysis of the
transcriptome, 41,040 sequences were identified by BLAST
analysis in 5 sequence databases. There was overall consensus
amongst the NCBI databases as to the hits on species, with the vast
majority of sequences matching to the horse. Further analysis of
the sequenced transcriptome revealed that 9,504 of the identified
sequences were missed by equine predicted databases, and 1,280
of the identified sequences have yet to be discovered in the equine
genome project. This is most likely due to the incomplete
annotation of the equine genome and differential expression of
the equine brain in disease allowing for detection of rare
transcripts. Since other species’ genomes have undergone more
comprehensive annotation and analysis, transcriptomic sequences
that should be recognized by the equine databases may be
recognized in other organisms. Another possibility for the
discrepancy could be differences between the equine genome
and transcriptome (i.e. splice variants). These issues are likely to
improve with time and more tissue specific transcriptome analyses.
This portion of the project also demonstrated high sequence
homology between the equine and human EST database, showing
that the horse may be useful in the study of the human organism.
The main hypothesis investigated was that there are families of
genes that are changed in a consistent manner in horses
undergoing WN encephalitis. In the analysis of the microarray
data, three subhypotheses were investigated to explore whether
there was a difference in gene expression based on the state of
exposure, immunity/survival, and location in the CNS. Because
there was high amount of overlap in our findings from these
analysis, either these findings support a generalized model of
WNV encephalitis based on exposure status, recovery, and CNS
pathology, or the state of WN infection without regard to
immunity and recovery has been primarily modeled. Alternatively,
Table 8. Summary of outcomes of each treatment group analyzed by CNS microarray.
Vaccine Clinical Signs Fever
b Survival
c Virus Isolation Histopathology
Infected Vaccinated (6) 0/6 0/6 0/6 0/6 1/6
e
Infected Nonvaccinated (6) 6/6
a 3/6 6/6 6/6 6/6
d
Noninfected (6) 0/0 0/0 0/0 0/0 0/0
aModerate or severe signs in at least one of the following categories for at least two days: mentation, paresis, fasciculation, or ataxia.
bBody temperature $39.2uC (102.5uF).
cDeath due to development of WNV disease severe enough to require euthanasia for humane reasons.
dEncephalitic horses in the control group had moderate or severe encephalitis on histopathology.
eMild inflammatory histopathologic changes in neural tissues vaccinated horses.
doi:10.1371/journal.pone.0024371.t008
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similar to a completely naı ¨ve, nonexposed state. Additionally, it is
likely that the time of sample collection (21 days for vaccinated/
exposed horses, 7–9 days for nonvaccinated/exposed horses)
influenced gene expression in immune horses. However, overall, it
appears that horses that are exposed to WNV demonstrate similar
changes in gene expression, which are highlighted by the changes
in the thalamus. Finally since the results appear to be location
dependent with the majority of differentially expressed genes in the
gray matter coinciding with disease/survivorship state, study of
WNV in the brain is topical and likely best elucidated in a tissue
specific manner.
A total of 17 neurological canonical pathways were identified
across the three analyses, the majority of which involved cell
signaling within the nervous system. Neurotransmitter pathways
were one of the top dysregulated pathways for all groups, including
glutamate and dopamine pathways. Glutamate is the primary
excitatory neurotransmitter in the neurological system. Previous
work has demonstrated that an excess of glutamate at the synaptic
cleft can lead to apoptosis of neurons through glutamate
excitotoxicity as a cause of pathology in many neurological
conditions [23,24,25,26,27]. In this study, the nonvaccinated
group of horses exposed to WNV demonstrated gene expression
changes consistent with glutamate excitotoxicity when compared
to both the vaccinated and normal (non-exposed) control horses.
This was also true when comparing the thalamus of the non-
vaccinated horses exposed to WNV to the cerebrum of these same
horses. Changes consistent with glutamate toxicity included a
decrease in the expression levels of NMDA glutamate receptors,
metabotropic glutamate receptors, kainate glutamate receptors,
Table 9. Histopathology on individual animals.
Treatment Animal Pathology Score in Cerebrum Pathology Score in Thalamus
Infected Vaccinated Horse 1 0(18) 0(17)
Infected Vaccinated Horse 2 1(13) 1(12)
Infected Vaccinated Horse 3 0(10) 3(43)
Infected Vaccinated Horse 4 0(2) 1(17)
Infected Vaccinated Horse 5 0(7) 0(3)
Infected Vaccinated Horse 6 0(2) 0(10)
Infected Nonvaccinated Horse 7 2(40) 29(93)
Infected Nonvaccinated Horse 8 4(58) 18(100)
Infected Nonvaccinated Horse 9 6(60) 11(82)
Infected Nonvaccinated Horse 10 7(75) 17(83)
Infected Nonvaccinated Horse 11 0 (8) 10(32)
Infected Nonvaccinated Horse 12 1(10) 7(50)
Not Infected Horse 13 00
Not Infected Horse 14 00
Not Infected Horse 15 00
Not Infected Horse 16 00
Not Infected Horse 17 00
Not Infected Horse 18 00
This table shows the lesions that were quantified in the pons, medulla, cervical cord and lumbar cord. Briefly cross sections of these areas were examined for the
presence of gliosis and perivascular cuffing. One section each was evaluated for the pons and medulla. Two sections were evaluated for each area of the spinal cord.
Total numbers of glial nodules were counted in each section. If more than one section was evaluated the counts for these sections were averaged. For pervascular cuffs,
3 areas were examined in each section and 10 vessels were counted in each area. The number of vessels that contained inflammatory cells was divided by the number
10. Each area per section was averaged.
doi:10.1371/journal.pone.0024371.t009
Table 10. Validation of the array.
Nonvaccinate average
relative expression QPCR
Vaccinate average relative
expression QPCR
Average expression
nonvaccinate: vaccinate QPCR
Nonvaccinate: vaccinate
array expression
2959OAS +1.689667 20.71533 +2.4050 +6.539663
Complement Component 1 r +2.0895 20.2185 +2.3080 +1.886843
DEADBox60 +1.7625 20.895 +2.6575 +5.651655
Defensin B4 +0.365333 21.907 +2.2723 +6.99401
IL-6 +1.342833 20.56933 +1.9122 +5.97945
TNF +0.649 20.90583 +1.5548 +3.471118
Comparison of the relative expression levels between the nonvaccinate and vaccinate thalamus and QPCR to array platforms.
doi:10.1371/journal.pone.0024371.t010
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tors. Infection with WNV may lead to a downregulation of
glutamate receptors on the post-synaptic neuron as well as
glutamate uptake receptors on glial cells, leading to an increase
in glutamate levels in the synaptic cleft and pathology associated
with glutamate excitotoxicity.
Dopamine was another neurotransmitter pathway that was
significantly changed in all three groups. Dopamine is a
stimulatory neurotransmitter that functions, among other things,
in the control of voluntary movement [28]. In the nonvaccinated
group of horses exposed to WNV, a decrease was seen in the
expression levels of dopamine receptor D5 as well as the
downstream affector transcripts AC, PC, and PP. In addition,
tyrosine hydroxylase, which catalyzes the conversion of tyrosine to
dopamine, was downregulated. The expression of monoamine
oxidase (MAO), which functions to breakdown dopamine, was
increased in the nonvaccinated exposed group. Thus exposure to
WNV may lead to a decrease in dopaminergic receptors and
subsequent downstream signaling, a decrease in enzymes to create
dopamine, as well as an increase in MAO. This results in a total
decrease in available dopamine, which may explain many of the
clinical signs seen in WNV infection that seem to mimic human
disorders such as Parkinson’s disease. Further study involving the
detection and quantification of the transcripts from neuronal cells
infected with WNV associated with the glutamic and dopaminer-
gic pathways is necessary before any firm conclusions can be
drawn.
Clinical neurological disease in horses caused by WNV is
characterized by a combination of spinal cord, midbrain/
hindbrain, and mentation abnormalities, with long-term residual
neurological deficits [29]. The clinical signs seen in horses during
WN infection mimic many of the clinical signs seen in some
human neurological disorders, such as Parkinson’s disease,
progressive motor neuropathy, Huntington’s disease, neurodegen-
eration, amyotrophic lateral sclerosis, and multiple sclerosis. For
this study, it was found that many of the pathways and transcripts
previously shown to be dysregulated during these diseases are also
abnormally expressed during WNV infection in horses. Thus
neurological infection with WNV in horses appears to mimic
many of the seemingly non-infectious neurological disorders seen
in man on both the clinical disease scale and the transcriptomic
level. It is possible that seemingly non-infectious neurological
disease may have an infectious origin, or that the brain can only
behave and react in a certain manner no matter the stimulus or
insult. This study demonstrated that infection with WNV leads to
dysregulation in known neurological disease gene pathways,
including those involved with neurotransmission and downstream
signaling. This corresponds with clinical signs of disease in affected
hosts, and also suggests a correlate between the neuropathology
induced by viral infection of the CNS and the neuropathology
seen in non-infectious neurological disease.
The similarities between the three analyses can also be seen
when examining the immunological pathways and functions. This
study demonstrated that changes in both the innate (inflammatory
response, antigen presentation, immune cell trafficking) and
adaptive (humoral immune response, cell-mediated immune
response, cytotoxicity, immune cell trafficking) immune pathways
are present during WNV infection. In general, the majority of
immune transcripts and pathways were decreased in expression in
the nonvaccinated horses exposed to WNV, providing evidence of
downregulation of a balanced immune response during WNV
infection at the peak of clinical disease.
In contrast, some immune pathways, such as the interleukin-15
signaling pathway, were upregulated during WNV infection in
nonvaccinated horses exposed to WNV. IL-15 has been shown to
be particularly important in providing a protective immune
response to viral infection [30,31,32,33]. For all three analyses, IL-
15 was upregulated over 2-fold, as well as the transcription factor
STAT1, which was upregulated over 2–3 fold. Interestingly, the
downstream elements of IL-15 were downregulated in the
unvaccinated horses exposed to WNV. The virus, either directly
or indirectly, may be blocking the downstream effector elements of
the IL-15 pathway to prevent the host immune response to the
virus. There could also be other elements in the IL-15 pathway
that are not yet elucidated. It is also possible that this finding is
only a reflection of the timing when the naı ¨ve horses exposed to
WNV were euthanized (at the onset of clinical signs) and a
beneficial response from IL-15 to viral infection could not be
realized in these horses. Thus it appears that IL-15 is upregulated
in response to WNV infection, and while it may play a key role in
recovery from viral infection, its dysregulation may be a key
component of the immunopathology of this disease. Continued
work targeting the quantification of IL-15 levels during viral
infection at different time points is necessary for further
clarification of this data.
Other pathways that were upregulated in non-vaccinated horses
exposed to WNV were the IL-22, the IL-9, and the interferon
signaling pathways with IL-22 and IL-9 activating similar
transcripts. Both of these pathways activate JAK and TYR
transcripts, which in turn phosphorylate and activate STAT
(Signal Transducers and Activators of Transcription)- specifically
STAT1, STAT3, and STAT5. These STAT transcripts induce the
expression of ISGs (interferon stimulated genes) through a variety
of mechanisms, and lead to the induction of an innate antiviral
response [34]. As expected, expression of these JAK/STAT
transcripts is upregulated during WNV infection in the unvacci-
nated horses exposed to WNV. Of interest as well is the finding
that the SOCS3 (suppressor of cytokine signaling 3) is also
upregulated in the exposure and survival analyses. SOCS3
functions as a negative feedback inhibitor on the JAK/STAT
pathway, thereby inhibiting the innate immune response [35].
Transcripts of SOCS1 and SOCS3 have been shown to increase
during WNV infection of the murine brain [36]. Upregulation of
SOCS3 allows the virus to escape the innate immune response and
has also been shown to lead to chronic infection and inflammation.
This is further supported by decreased expression of the
transcriptional regulators ASB1 and ASB5, which function to
suppress SOCS expression. Thus it is possible that while the JAK/
STAT pathway is upregulated in response to WNV infection for
the activation of innate immunity, WNV may induce the
expression of the SOCS3 molecule to suppress this pathway and
evade the innate immune response.
The transcript increased the most in expression for all analyses
was pentraxin 3 (PTX3). This was the case for all analyses when
comparing the unvaccinated exposed horses to the vaccinated
exposed and normal horses, as well as the thalamus to the
cerebrum (thus the highest levels of expression were in the
unvaccinated controls). This molecule has many functions,
including an integral role in the pathway of pattern recognition
receptors in recognition of viruses and bacteria [37,38]. This gene
is induced by IL-1b, and functions in the phagocytosis and
opsonization of antigens, as well as in the inflammatory response.
Thus infection with WNV and recovery from disease may be
associated with an increase in this molecule that plays an integral
role in innate immunity. Another transcript that was highly
increased in expression for all analyses (greatest level of expression
in the non-vaccinated controls compared to other groups and in
the thalamus compared to the cerebrum) was the brain specific
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cytoskeletal architecture with signaling pathways [39]. This may
provide evidence that dysregulation of neurological tissue, such as
that induced during WNV infection, leads to re-arrangement of
neuronal architecture and the induction of signaling. This may
also be important in viral entry into the cell. Apoptotic transcripts
that were upregulated in all analyses included PARP and CASP4.
Some apoptotic transcripts were upregulated in only the exposure
analysis, including RXR and its receptor RAR. Understanding
which transcripts are upregulated or downregulated during viral
infection provides a glimpse into the affect of the virus on
individual transcripts and, with further studies, could lead to the
elucidation of many unanswered questions. These could include
an understanding of how the virus invades the cell, as well as
which cell molecules the viruses uses for replication, transcription,
and translation.
The changes in gene expression data were also compared to
clinical signs and histopathological data. Horses that were infected
and not vaccinated demonstrated abnormal neurological and
clinical signs as well as viremia, warranting humane euthanasia by
day 9 of the study. On histopathological analysis, these horses also
demonstrated moderate to severe signs of encephalitis, worse in
the thalamus than in the cerebrum. This was in comparison to the
vaccinated, exposed horses and normal horses that did not display
any abnormal clinical or neurological signs and did not have a
detectible viremia. Only a mild encephalitis was seen in 1 of the 6
vaccinated and exposed horses, with no abnormal histology in the
normal controls. This correlates well to the gene expression data,
as the non-vaccinated exposed horses demonstrated the greatest
changes in gene expression when compared to the other groups of
horses. The severity of the clinical signs and histopathology in the
non-vaccinated horses exposed to WNV, compared to the exposed
vaccinates and normal controls, is consistent with the changes in
gene expression seen between the analyses of exposure and
survival. This is likewise true for the location analysis when
examining the histopathological differences between the thalamus
and cerebrum of the exposed, non-vaccinated horses.
In summary, the microarray proved to be a useful tool to
understand changes in gene expression patterns during WNV
infection utilizing a custom fabricated microarray enriched for
neurological and immunological sequences for study in the
clinically affected host. Significant changes were identified in
neurological, immunological, and apoptotic pathways with
associations made between viral encephalitis and non-infectious
neurological disease based on a systems biology approach. This
information will eventually be integrated with other components of
a systems biology approach, combining interdisciplinary scientific
fields to validate these findings. This information could eventually
be used to combat not only outbreaks of WNV, but also as a model
to understand and reduce the impact of viral encephalitis in
general.
Supporting Information
Methods S1 Supplemental methods information, in-
cluding information on RNA extraction and quality
assessment, the construction and normalization of the
cDNA library, production of samples for analysis on the
array, hybridization and scanning of the arrays, and
microarray validation.
(DOCX)
Figure S1 Gene ontology classification of physiological
processes. These categories were included under biological
process. The majority of genes were involved with neurophysio-
logical processes (1,920) and the immune response (1,272).
(TIF)
Figure S2 Sequence count by species group for the
NCBI NR/NT databases. A.) Sequence count for the NR
database. The majority of sequences mapped to the horse, with
other prominent groups including the human, primate, canine,
and bovine. B.) Sequence count for the NT database. The
majority of sequences in this database also mapped to the horse,
with other prominent groups including the human, primate,
canine, and bovine.
(TIF)
Figure S3 Average length of novel sequences. The
majority of sequences annotated were less than 1000 base-pairs,
with an average length of 595 base-pairs.
(TIF)
Figure S4 Box plots for Loess normalization. The green
line indicates the mean of all arrays after normalization, while the
red boxes indicate the range of response, the red lines in the boxes
the median of each array, and the extended red lines standard
deviations. All arrays normalized correctly.
(TIF)
Figure S5 Heat Map and Dendrogram of All Arrays
Demonstrating Similarity in Gene Expression. Dark red
indicates a high degree of similarity, while blue indicates a low
degree of similarity.
(TIF)
Figure S6 Number of Genes that Mapped to GO
Categories for All Analyses and Distribution of Genes
Among GO Categories. A. The distribution of genes is
relatively even, with slightly more genes overall in the exposure
analysis compared to the nonsurvival and location analysis. B.
Most genes for all analyses were classified under transcriptional
categories, with neurological categories containing the second
highest number of genes. For the purposes of this study, ‘exposure’
represents the difference in gene expression between the
nonvaccinated/exposed-normal, ‘survival’ represents the differ-
ence in gene expression between the nonvaccinated/exposed-
vaccinated/exposed, and ‘location’ represents the difference in
gene expression between the thalamus and cerebrum of the
nonvaccinated/exposed.
(TIF)
Figure S7 Immunological and cell death/apoptosis
functions for all analyses. The majority of all transcripts
mapped to the exposure analysis. Both innate and adaptive
immune categories are present, as well as both cell death and
apoptosis. For the purposes of this study, ‘exposure’ represents the
difference in gene expression between the nonvaccinated/
exposed-normal, ‘survival’ represents the difference in gene
expression between the nonvaccinated/exposed-vaccinated/ex-
posed, and ‘location’ represents the difference in gene expression
between the thalamus and cerebrum of the nonvaccinated/
exposed.
(TIF)
Table S1 Probe groups for inclusion on the microarray.
Probes were included on the array once in the ‘plus’ (59–39)
orientation (Annotated). Probes were individually selected to be
included twice on the array (Important analyse) and included
sequences involved in neurological, immunological, and transcrip-
tional processes, as well as cell death. Probes that were determined
to be correctly oriented in the ‘minus’ (39–59) direction were
Equine Host Response to West Nile Virus Infection
PLoS ONE | www.plosone.org 17 October 2011 | Volume 6 | Issue 10 | e24371included in Annotated_minus. Unannotated probes and probes
recovered from the EqCab2 genome sequencing project were also
included. 250 Agilent controls were incorporated.
(DOCX)
Table S2 Average Nucleic Acid Quality Data for All
Samples. Quality assessment was performed on all RNA samples
used to create the cDNA library. The quality of the RNA was
checked using spectrophotometric technology (ND-1000, Nano-
drop Technologies, Wilmington, DE) and a microfluidics platform
(Agilent 2100 Bio-analyzer, Santa Clara, CA). Only samples with a
RIN.6 and a 260:280 ratio .1.80 were used in the experiment.
Quality assessment was also performed on the cDNA libraries
including the 260:280 ratio (.1.80) and concentration measure-
ments.
(DOCX)
Table S3 Data from 454 Sequencing Runs Newbler
Assembler. Newbler assembly software was first used to
assemble the sequences. 514,462 sequences were assembled from
a total of 49,857,586 bases after linker contamination was
removed. Sequences that could be linked from beginning to end
were classified as ‘fully assembled reads’, sequences that were
shown to have some association were classified as ‘partially
assembled reads’, standalone sequences coding once for areas of
individual genes were classified as ‘singletons’, standalone
sequences coding for areas of individual genes at a frequency of
greater than 5% were classified as ‘repeats’, and standalone
sequences coding for areas of individual genes at a frequency of
less than 5% were classified as ‘outliers’. From this data, 16,895
contigs (sets of overlapping DNA sequences) composed of
4,720,747 bases were assembled.
(DOCX)
Table S4 Average Scores for Equine Databases. The
average scores for the equine databases indicate a high degree of
sequence alignment with the sequences that matched. [HspScore
(high-scoring segment pair)- measures degree of local alignments
with no gaps. Higher scores indicate better alignment. BitScore-
statistical accounting of the raw alignment score which is the sum
of the substitution and gap scores. Higher scores indicate better
alignment. Average hit length- the length of the sequences that
align.]
(DOCX)
Table S5 Number of significant genes for each analysis.
The number of significant genes for each analyse (with and
without duplicate removal) was determined. An ANOVA with
interactions (p,0.05) was used to determine significance.
(DOCX)
Table S6 Canonical pathways for all analyses. All
significant canonical pathways for all analyses are listed. The *
denotes pathways involved with the nervous system (11), while the
‘ denotes pathways involved with the immunological response (4).
(DOCX)
Table S7 Functions for all analyses. The number of
transcripts for significant functions for all analyses are listed. The
* denotes functions involved with the nervous system (6) while the
‘ denotes functions involved with the immunological system (11).
(DOCX)
Table S8 Transcripts for all analyses mapped to
immunological CPs. This table shows the number of
transcripts that mapped to each pathway for all analyses. The
majority of the transcripts demonstrated a decrease in expression
values. Transcripts were included if they demonstrated a fold
change .1o r,21.
(DOCX)
Table S9 Specific clinical signs of horses by group
analyzed by CNS microarray. Horses were graded as no
increase in clinical signs, a moderate to mild increase in clinical
signs, and a severe increase in clinical signs for all studies. Clinical
signs observed included changes in mentation, paresis, ataxia, and
muscle fasciculations. The nonvaccinated group exposed to West
Nile virus demonstrated the most severe increase in severity of
clinical signs, while the vaccinated/exposed group and normal
controls did not show any changes in clinical signs.
(DOCX)
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